Jes Olensen, clinical professor in the department of clinical neurology, Rigshospitalet, Denmark, has been awarded the Brain Prize along with Michael Moskowitz, Lars Edvinsson and Peter Goadsby for discovering a key mechanism that causes migraine which has since led to revolutionary new treatments.
Parkinson’s Disease Costs Europe €22.8 Billion A Year As Cases Rise – COIN-Eu Study
September 2, 2026
The annual societal cost of Parkinson's disease across Europe reached €22.8 billion in 2019 according to a new study within the EAN-led Cost of Illness in Neurology in Europe (COIN-Eu) initiative.
First EAN Annual Report Reviews Major Milestones of 2025
August 7, 2026
Latest Posts
-
-
Other News
European Research Area Network Coordinating National and Regional Funding for the Future and Emerging Technologies Flagships (FLAG-ERA) Calls
March 4, 2021FLAG-ERA gathers National and Regional Funding Organisations (NRFOs) in Europe and beyond with the goal of supporting, together with the European Commission, the FET Flagship initiatives, i.e., the Graphene Flagship and the Human Brain Project (HBP) Flagship. -
InterviewsEAN NewsCOVID-19
COVID-19 around the World: Clinician interviews on experience and impact of the virus (Cape Verde)
March 3, 2021COVID-19 around the World: Clinician interviews on experience and impact of the virus (Cape Verde) -
News from EAN member societiesOther News
News from EMA: First oral treatment for spinal muscular atrophy (SMA) recommended for approval
March 3, 2021News from EMA: First oral treatment for spinal muscular atrophy (SMA) recommended for approval -
EAN NewsResearchOther News
Brain Talks: Professor Günther Deuschl addresses burden of neurological diseases in Europe
March 3, 2021Brain Talks: Professor Günther Deuschl addresses burden of neurological diseases in Europe -
Breaking newsCOVID-19Research
Serum and CSF alpha-synuclein levels do not change in COVID-19 patients with neurological symptoms
March 3, 2021Serum and CSF alpha-synuclein levels do not change in COVID-19 patients with neurological symptoms -
Breaking newsCOVID-19Research
COVID-19 continuous-EEG case series: A Descriptive Study
March 3, 2021COVID-19 continuous-EEG case series: A Descriptive Study -
Breaking newsCOVID-19Research
Acute ischemic stroke and COVID-19: An analysis of 27 676 Patients
March 3, 2021Acute ischemic stroke and COVID-19: An analysis of 27 676 Patients -
Breaking newsCOVID-19Research
Inflammatory cytokine patterns associated with neurological diseases in COVID-19
March 3, 2021Inflammatory cytokine patterns associated with neurological diseases in COVID-19 -
Breaking newsCOVID-19Research
Susceptibility of neuroblastoma and glioblastoma cell lines to SARS-CoV-2 infection
March 3, 2021Susceptibility of neuroblastoma and glioblastoma cell lines to SARS-CoV-2 infection -
Breaking newsCOVID-19Research
Latent class cluster analysis identified hidden headache phenotypes in COVID-19: impact of pulmonary infiltration and IL-6
March 3, 2021Latent class cluster analysis identified hidden headache phenotypes in COVID-19: impact of pulmonary infiltration and IL-6 -
Breaking newsCOVID-19Research
Neurological manifestations as primary presentation of COVID-19 in hospitalized patients
March 3, 2021Neurological manifestations as primary presentation of COVID-19 in hospitalized patients -
Breaking newsCOVID-19Research
Cerebrospinal fluid in COVID-19: A systematic review of the literature
March 3, 2021Cerebrospinal fluid in COVID-19: A systematic review of the literature -
Breaking newsCOVID-19Research
Impact of coronavirus disease 2019 in a French cohort of myasthenia gravis
March 3, 2021Impact of coronavirus disease 2019 in a French cohort of myasthenia gravis -
Breaking newsCOVID-19Research
Increased worsening of amyotrophic lateral sclerosis patients during COVID-19-related lockdown in France
March 3, 2021Increased worsening of amyotrophic lateral sclerosis patients during COVID-19-related lockdown in France









